Tag: lymphoma

The latest edition of Dialogue magazine from the Wilmot Cancer Institute is about progress, gratitude, and achievement, as the cancer center reaches its 50-year milestone.

Get to know Jamie Flerlage, MD, MS. She recently joined URMC as the new Chief and Academic Director of Pediatric Hematology/Oncology at Golisano Children's Hospital and Assistant Director of Clinical ...

From basic science to communications tools for cancer patients, Wilmot researchers are making an impact.

Thanks to a groundbreaking nationwide study with Wilmot Director Jonathan Friedberg at the helm, a practice-changing treatment emerged for young people with Hodgkin lymphoma.

In a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s, showed signs of being an average of 7.7 years older biologically than their peers.

Two major clinical trials are changing the landscape in the most common form of lymphoma.

Jodi Lown has always dreamt of going to France. She had no idea a lymphoma diagnosis would bring France to her, in the form of a stem cell transplant, or that she would find a way to return an active ...

Launched by Megan Donovan, RN, the Walk n’ Roll program on Wilmot’s Hematology/Oncology Unit on the seventh floor (WCC7) encourages patients to walk more during their hospitalization.

Patrick Reagan, M.D., looks at the data on his computer screen and a rare grin spreads across his face. His most recent study results for patients with end-stage mantle cell lymphoma show that an ...

In autumn of 2017, Nicole Zaleski-Conine experienced side effects she chalked up to a host of reasons, but in January 2018, the definitive diagnosis came in: follicular lymphoma that transformed into ...